SCHEMBL7308154

SCHEMBL7308154

Cc1cccc(COC(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)[C@@H]2O[C@@H]2[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)OCc2cccc(C)n2)C(C)C)C(C)C)n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.46
CTSD P07339 2/20 0.43
CASP3 P42574 2/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
CYP2D6 P10635 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CA1 P00915 1/20 0.40
CYP2C9 P11712 2/20 0.39
ECE1 P42892 2/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
MME P08473 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
CASP6 P55212 1/20 0.39
CASP8 Q14790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299990 0.87 CA2 (0.48) CYP3A4CTSDCASP3CTSBCTSS
SCHEMBL7299914 0.86 CASP3 (0.49) CYP3A4CTSDCASP3CASP1CASP7
SCHEMBL7306108 0.86 CTSD (0.55) CTSDCASP3CTSBCTSSCTSK
SCHEMBL7295829 0.84 CYP3A4 (0.43) CYP3A4CTSDCASP3CTSBCTSS
SCHEMBL7304710 0.79 CTSL (0.47) CYP3A4CTSDCASP3CTSBCTSS
SCHEMBL7303071 0.78 TYR (0.46) CTSBCTSSCTSKECE1MME
SCHEMBL7298552 0.78 TYR (0.46) CTSBCTSSCTSKECE1MME
SCHEMBL8669118 0.78 CTSD (0.49) CTSDCASP3CTSBCTSSCTSK
SCHEMBL7330521 0.77 CTSD (0.49) CYP3A4CTSDCASP3CTSBCTSS
SCHEMBL7307873 0.76 MEN1 (0.41) CTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed